“Superlative transactional IP work, especially in cutting-edge technologies, such as blockchain, medical technology and machine learning“ IAM MAGAZINE 2019
February 20, 2020>>
Yuval Horn noted once again as a Thought Leader Global Elite 2020 in Life Sciences by Who’s Who Legal, the only individual from Israel.
January 20, 2020>>
“They were providing services to one of the more innovative projects coming out of Israel in blockchain and trying to secure SEC approval for a project, which is very difficult to get.”
December 18, 2019>>
Paz Abercohen, Yuval Horn and Yonatan Levinstein of Horn & Co. represented Raziel Therapeutics in its $22 million series C round, led by Pontifax, with participation from existing investors as well as new investors, Catalyst Fund, Quark venture, Peregrine Investments and Wille AG.
October 10, 2019>>
Yuval Horn will moderate a panel about AI and eHealth disruption in the medical and lifestyle markets with Markus von Fuchs at the upcoming IBA 6th Biennial Technology Law Conference in Berlin.
September 25, 2019>>
Yuval Horn moderated a panel with Rabel Z. Akhund on the regulation of crypto trading platforms.
September 24, 2019>>
Yuval Horn moderated, with Doil Son of Yulchon (Seoul) a panel on Data in M&A at the Annual Meeting of the International Bar Association in Seoul.
September 15, 2019>>
Paz Abercohen of Horn & Co. represented Biolight Life Sciences Ltd. in its investment in Sanoculis Ltd., a medical device company which develops an innovative surgical procedure for treatment of Glaucoma